TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant schizophrenia. The Phase 2 ...
Morning Overview on MSN
Scientists edited human embryo genes with startling precision, researchers report
Two separate research teams used base editing to make single-nucleotide changes in human embryos this month, targeting genes ...
United Therapeutics is a Buy: strong core growth, a goal of $1B quarterly revenue by 2027, plus catalysts ralinepag & Tyvaso ...
The Indian government has strengthened oversight of cell and gene therapies by bringing the novel modalities into the ...
The Manila Times on MSN
Slain motorist's family seeks justice as suspect surrenders in Iloilo
ILOILO CITY — Justice is within reach for the family of a slain motorist in this city, following the surrender of a dismissed police officer who had been evading an arrest warrant for nearly four ...
The ongoing battle against neglected tropical diseases (NTDs) and pandemic pathogens such as COVID-19 has exposed significant deficiencies in our ...
Objectives Elective non-emergent surgical wait times have increased across countries such as Canada, straining operating room ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results